Breakthrough by SFS Doctors

Some notable breakthroughs include:

  • 1982: First to recommend the exclusive use of gonadotropins to stimulate follicular development for IVF.
  • 1983: First to introduce Intrauterine Insemination (IUI) of washed sperm for treating certain forms of infertility.
  • 1989: First to report on ultrasound appearance and thickness of the uterine lining (endometrium) as a predictor of IVF success.
  • 1993: First to introduce the technique of “Prolonged Coasting” for cases of Severe Ovarian Hyperstimulation. This treatment protocol has virtually eliminated the life-endangering effects of this condition as well as eliminating the need to cancel the patient’s IVF cycle.
  • 1994: First to identify and treat immune factors affecting implantation potential of embryos in certain women.
  • 1997: First to introduce Viagra to enhance the thickness of the uterine lining in IVF patients.
  • 1998: First to recommend the selective use of intravenous gammaglobulin for the treatment of certain forms of Immunologic Implantation Dysfunction (IID) in IVF.
  • 2000: First to introduce a new protocol of ovarian stimulation, the agonist/antagonist conversion protocol (A/ACP) to improve egg/embryo quality in response to gonadotropin stimulation. This also led to the addition of advanced “priming” with estradiol valerate (A/ACP-E2V) to further augment the response of women with reduced ovarian reserve (“poor responders”).
  • 2003: First to measure soluble Human Leukocyte Antigen-G (sHLA-G) in the media surrounding early individual embryos and use this genetic marker to identify the “best individual embryos” (the ones that are most likely to implant and produce a viable pregnancy) for transfer to the uterus.
  • 2005: First to show, by using Pre-Implantation Genetic Testing (PGT) with Comparative Genomic Hybridization (CGH), that an embryo resulting from fertilization of a chromosomally normal (euploid egg), has a much improved ability to implant successfully and produce a normal baby. This method which tests egg/embryo “competence” is likely to vastly improve IVF results and lead to single embryo transfers, thereby minimizing the risk of multiple pregnancies.
  • 2007: First to show, by using PGT with CGH that an embryo resulting from fertilization of a euploid egg (i.e. an egg that has all of its chromosomes present), has a much improved ability to implant successfully and produce a normal baby. To date more than 400 babies have been born using this technique.
  • 2008: First to apply PGT with metaphase CGH to the selection of chromosomally intact eggs for cryobanking, leading to a four to six-fold improvement in the birth rate per frozen egg over that which had been previously reported. To date, many babies have been born from his use of CGH tested eggs.
  • 2014: Supplanted CGH embryo testing with a new PGT method known as Next Generation Gene Sequencing (NGS) for testing the competency of embryos and eggs.

More Resources

Ask our Doctors

Have a fertility question? You are not alone. Our doctors are here to answer your questions and support you on your fertility journey.

Ask Our Doctors

Learn From the Fertility Experts

Explore the latest videos from the SFS Physicians. They're here to share their perspectives on various fertility topics with you.


Fertility Topics Explained from the Experts at SFS

Read the latest fertility blogs by our physicians on the latest in the fertility field.


Begin Your Fertility Journey

Sher Fertility Solutions is here to help you create your family.

Book A Consultation


Sher Fertility Solutions
425 5th Ave.
New York, NY 10016

Dr. Tortoriello (646)792-7476
Dr. Sher (702)533-2691